These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4438990)

  • 41. Managing hyperlipidaemia.
    Nestel PJ
    Med J Aust; 1988 Jan; 148(1):29-31. PubMed ID: 3336296
    [No Abstract]   [Full Text] [Related]  

  • 42. Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs.
    Idrees GA; Aly OM; Abuo-Rahma Gel-D; Radwan MF
    Eur J Med Chem; 2009 Oct; 44(10):3973-80. PubMed ID: 19450906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modern management of hyperlipidemia.
    Grundy SM
    Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
    [No Abstract]   [Full Text] [Related]  

  • 44. [A trial of the use of the hypolipidemic preparation Lipanor (ciprofibrate) in patients with primary hyperlipidemia].
    Kukharchuk VV; Rozhkova TA; Kotova LA; Tvorogova MG; Semenova OA
    Ter Arkh; 1996; 68(6):58-61. PubMed ID: 8771689
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Classification of the hyperlipoproteinemias].
    Huth K
    Med Klin; 1970 Apr; 65(14):637-43. PubMed ID: 4927439
    [No Abstract]   [Full Text] [Related]  

  • 46. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
    Gustafson A
    Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
    [No Abstract]   [Full Text] [Related]  

  • 47. Hypolipidemic effect of low-dose oral charcoal in diabetic rats.
    Friedman EA; Manis T; Zeig S; Lum GY
    Clin Nephrol; 1979 Feb; 11(2):79-80. PubMed ID: 455814
    [No Abstract]   [Full Text] [Related]  

  • 48. [Efficacy of procetofen (lipanthyl) in hyperlipidemias (author's transl)].
    Stähelin HB; Seiler W; Pult N
    Schweiz Rundsch Med Prax; 1979 Jan; 68(1):24-8. PubMed ID: 760103
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia].
    Rouffy J; Loeper J
    Therapie; 1972; 27(3):433-44. PubMed ID: 4570211
    [No Abstract]   [Full Text] [Related]  

  • 50. Ten years' dietary treatment of primary hyperlipidemia.
    Lewis LA; Brown HB; Page IH
    Geriatrics; 1970 Dec; 25(12):64-81. PubMed ID: 5483788
    [No Abstract]   [Full Text] [Related]  

  • 51. Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
    Aronow WS; Vangrow JS; Nelson WH; Pagano J; Papageorge's NP; Khursheed M; Harding PR; Khemka M
    Curr Ther Res Clin Exp; 1973 Dec; 15(12):902-6. PubMed ID: 4203573
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of hyperlipemias with lipolytic drugs].
    Jover Sanz E; Paradinas Jiménez C; Corporales López L; Martínez Robles JV
    Rev Clin Esp; 1974 Jun; 133(5):447-50. PubMed ID: 4428087
    [No Abstract]   [Full Text] [Related]  

  • 53. [Studies on the effect of d-thyroxine in patients with increased serum lipid level].
    Steger H
    Wien Klin Wochenschr; 1968 Nov; 80(47):887-98. PubMed ID: 5717659
    [No Abstract]   [Full Text] [Related]  

  • 54. [Arteriosclerosis--nicotinic acid therapy. 7. Effect of nicotinic acid on lipoproteins].
    Carlson LA
    Lakartidningen; 1971 Apr; 68(15):1763-4. PubMed ID: 5577249
    [No Abstract]   [Full Text] [Related]  

  • 55. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment of primary hyperlipoproteinemia type II B with diet and niamide].
    Plamieniak Z; Szklarz E; Stepien-Dobrowolska M; Milewicz A
    Wiad Lek; 1977 Jan; 30(1):15-7. PubMed ID: 835255
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effect of sodium d-thyroxine on the hiperlipedemia, hypercholesteremia, triglycerides and serum lipoproteins in patients with arteriosclerosis].
    Mazzei ES; Mazzei CM; Gotelli C
    Prensa Med Argent; 1967 Mar; 54(5):199-203. PubMed ID: 5605172
    [No Abstract]   [Full Text] [Related]  

  • 59. [Epidemiological study of disorders of blood lipid equilibrium in the urban population (study of 7085 persons)].
    Mincu I; Cämpeanu S; Dumitrescu C; Mihaiache N; Stănescu V; Georgescu S; Mironescu M; Aron L; Bruckner I
    Med Interna (Bucur); 1972 May; 24(5):583-606. PubMed ID: 5049870
    [No Abstract]   [Full Text] [Related]  

  • 60. [Lipid lowering: myth or therapeutic necessity?].
    Dtsch Med Wochenschr; 1998 Oct; 123(40 Suppl):2-8. PubMed ID: 9793486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.